Understanding Symptoms After Lyme Disease Treatment
Part of Infections clinical trials.
This research study examines why some people continue to have symptoms months after being treated for Lyme disease. Researchers will compare patients with ongoing symptoms to people who recovered well, to better understand what causes lasting problems and how to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 13 or older (if you have suspected post-treatment Lyme disease) or age 18+ (if you're a control participant)
- Confirmed or probable Lyme disease diagnosed by a doctor (for main patient group)
- Completed recommended antibiotic treatment for Lyme disease
- Symptoms lasting at least 6 months after finishing antibiotics (for main patient group)
- No other medical explanation for your current symptoms
- No serious autoimmune diseases, chronic illnesses, or use of immune-suppressing medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study evaluates and treats people who currently have active Lyme disease, as defined by CDC criteria. It aims to provide expert care and follow-up while studying the disease.
This study explores the experiences of people who had Lyme disease during pregnancy or had ongoing Lyme symptoms throughout their pregnancy. By sharing your story in a recorded interview, you can help doctors and researchers better support parents with Lyme disease.
This study looks at how Lyme disease during pregnancy might affect a baby's development. It involves questionnaires and possibly an MRI of the baby's brain, done at a visit or remotely.
This study looks at how a person’s immune system responds after exposure to Ixodes (black-legged) tick bites. It aims to better understand the body’s early immune reaction after tick exposure, using blood tests and small skin samples.
This study looks at how your immune system responds to the bacteria that causes Lyme disease. It may help doctors better understand the disease and improve treatment. The trial includes people with a specific form of Lyme called acrodermatitis chronica atrophicans (a skin condition) and healthy volunteers.
This study is for people who have already received four doses of the Lyme vaccine (VLA15) in a previous study. It tests whether a fifth dose is safe and helps the body build more protection against Lyme disease.
Hear when a new Lyme Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.